Maxmarvil sales on the rise with added indications.

Yuyu has changed the label of Maximarvil, an anti-osteoporosis drug, in which the patient may allow to lie down after medication of Maximarvil, which may increase its sales in such a severe market competition with many foreign multinational drug corporations, targeting more than 10 billion won of the market per year.

Maximarvil is a combined anti-osteoporosis drug formulated with Alendronate...